Written by LINDSEY TANNER and LAURAN NEERGAARD

Health authorities are trying to determine whether heart inflammation that can occur along with many types of infections could also be a rare side effect in teens and young adults after the second dose of COVID-19 vaccine.

An article on seven U.S. teen boys in several states, published online Friday in Pediatrics, is among the latest reports of heart inflammation discovered after COVID-19 vaccination, though a link to the vaccine has not been proven.

The boys, aged 14 to 19, received Pfizer shots in April or May and developed chest pain within a few days. Heart imaging tests showed a type of heart muscle inflammation called myocarditis.

None were critically ill. All were healthy enough to be sent home after two to six days in the hospital and are doing ’’doing pretty well,” said Dr. Preeti Jaggi, an Emory University infectious disease specialist who co-authored the report.

She said more follow-up is needed to determine how the seven fare but that it’s likely the heart changes were temporary.

Only one of the seven boys in the Pediatrics report had evidence of a possible previous COVID-19 infection and doctors determined none of them had a rare inflammatory condition linked with the coronavirus.

The cases echo reports from Israel in young men diagnosed after receiving Pfizer shots.

The U.S. Centers for Disease Control and Prevention alerted doctors last month that it was monitoring a small number of reports of heart inflammation in teens and young adults after the mRNA vaccines, the kind made by Pfizer and Moderna.

The CDC hasn’t determined if there’s really a link to the shots, and continues to urge that everyone 12 and older get vaccinated against COVID-19, which is far riskier than the vaccine. The Pfizer vaccine is available to those as young as 12; the Moderna shot remains cleared only for adult use.

This kind of heart inflammation can be caused by a variety of infections, including a bout of COVID-19, as well as certain medications — and there have been rare reports following other types of vaccinations.

Authorities will have to tease out whether cases following COVID-19 vaccination are occurring more often than that expected “background rate.”

For now, the CDC says most patients were male, reported symptoms after the second dose, and their symptoms rapidly improved.

“I think we’re in the waiting period where we need to see whether this is cause-and-effect or not,” said John Grabenstein of the Immunization Action Coalition, a former director of the Defense Department’s immunization program.

A Pediatrics editorial noted that among U.S. children under age 18, there have been over 4 million COVID-19 cases, more than 15,000 hospitalizations and at least 300 deaths.

It said the heart inflammation cases warrant more investigation but added that ’’the benefits of vaccination against this deadly and highly transmissible disease clearly far outweigh any potential risks.”

Editorial co-author Dr. Yvonne Maldonado, head of an American Academy of Pediatrics infectious diseases committee, is involved in Pfizer vaccine studies, including a COVID-19 vaccine study in children.

 

Related Stories
‹
Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine
Written by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]
US Clears Updated COVID Boosters Targeting Newest Variants
Written by LAURAN NEERGAARD The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope […]
Moderna Seeks To Be 1st With COVID Shots for Littlest Kids
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
US Regulators Give Full Approval to Pfizer COVID-19 Vaccine
Written by LAURAN NEERGAARD and MATTHEW PERRONE The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet. The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the […]
Extra COVID Vaccine OK’d for Those With Weak Immune Systems
Written by LAURAN NEERGAARD and MATTHEW PERRONE U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge. The late-night announcement Thursday by the Food and Drug Administration applies to several […]
Pfizer COVID-19 Shot Expanded to U.S. Children as Young as 12
Written by LAURAN NEERGAARD and CANDICE CHOI U.S. regulators on Monday expanded the use of Pfizer’s COVID-19 vaccine to children as young as 12, offering a way to protect the nation’s adolescents before they head back to school in the fall and paving the way for them to return to more normal activities. Shots could begin […]
National Expert: Getting Kids Vaccinated Before School is 'Best Thing to Do'
Younger children are the age demographic that had the longest waits for COVID-19 vaccines to be approved. So far, their vaccination rates reflect that gap of time, but urgency around getting those initial doses has slowed to a crawl. With a new school year being just around the corner, though, federal health officials are saying […]
Marathon US Hearings To Decide Fate of COVID Shots for Tots
Written by LAURAN NEERGAARD Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week. On Wednesday, both Moderna and Pfizer will have to convince what’s essentially a science court — advisers to the Food and Drug Administration — that their shots work well in babies, toddlers and […]
Moderna Announces Step Toward Updating COVID Shots for Fall
Written by LAURAN NEERGAARD Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant. On Tuesday, it reported a preliminary hint that such an approach might work. Today’s COVID-19 vaccines all are based on the original version of the coronavirus. But the virus continues […]
Moderna Says Its Low-Dose COVID Shots Work for Kids Under 6
Written by LAURAN NEERGAARD Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers, the company announced Wednesday — and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer. Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose […]
›